Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis
- 1 May 2001
- Vol. 19 (25-26) , 3420-3431
- https://doi.org/10.1016/s0264-410x(01)00066-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from NigerThe Pediatric Infectious Disease Journal, 2000
- Meningococcal vaccine in sub-Saharan AfricaThe Lancet, 1997
- Meningococcal vaccine in sub-Saharan AfricaThe Lancet, 1997
- Meningococcal vaccine in sub-Saharan AfricaThe Lancet, 1997
- Meningococcal vaccine in sub-Saharan AfricaThe Lancet, 1997
- Epidemiology and prevention of meningococcal diseaseThe Pediatric Infectious Disease Journal, 1995
- Use and Misuse of the Term “Cost Effective” in MedicineNew England Journal of Medicine, 1986
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- EPIDEMIC OF MENINGOCOCCAL MENINGITIS IN BAMAKO, MALI: EPIDEMIOLOGICAL FEATURES AND ANALYSIS OF VACCINE EFFICACYThe Lancet, 1982
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977